Public limited company · Leuven · incorporated on 28/03/2013
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -28,4 k € | -176.7% | -10,2 k € | +78.8% | -48,4 k € | +15.1% | -57,0 k € | -104.4% | 1,3 M € | +16.3% | 1,1 M € | +45.0% | 761,6 k € | -50.2% | 1,5 M € | +82.3% | 839,3 k € | +277.4% | -473,2 k € | -166.3% | -177,7 k € | +69.8% | -587,9 k € | |
| EBITDA | -28,4 k € | -176.7% | -10,2 k € | +80.0% | -51,3 k € | +18.1% | -62,6 k € | -109.4% | 664,2 k € | +202.5% | 219,6 k € | +284.8% | -118,9 k € | -115.1% | 785,5 k € | +142.7% | 323,6 k € | +140.0% | -808,0 k € | -83.7% | -439,9 k € | +46.8% | -827,4 k € | |
| Operating profit | -28,4 k € | -176.7% | -10,2 k € | +80.0% | -51,3 k € | +18.1% | -62,6 k € | -109.7% | 645,2 k € | +127.0% | -2,4 M € | -1.4% | -2,4 M € | -152.1% | -935,3 k € | -27.8% | -731,6 k € | +11.7% | -829,0 k € | -83.3% | -452,3 k € | +46.0% | -837,3 k € | |
| Profit/loss | -28,8 k € | -198.5% | -9,7 k € | +81.7% | -52,9 k € | +16.3% | -63,2 k € | -108.6% | 733,7 k € | +132.4% | -2,3 M € | -2.0% | -2,2 M € | -142.1% | -916,0 k € | -25.1% | -731,9 k € | +11.7% | -829,2 k € | -83.8% | -451,0 k € | +45.9% | -833,9 k € | |
| Equity | 337,8 k € | -7.9% | 366,6 k € | -2.6% | 376,3 k € | -12.3% | 429,2 k € | -12.8% | 492,4 k € | +304.1% | -241,3 k € | -111.9% | 2,0 M € | -52.3% | 4,2 M € | +201.9% | 1,4 M € | +58.5% | 885,9 k € | +23.9% | 715,1 k € | -38.7% | 1,2 M € | |
| Total assets | 338,0 k € | -7.8% | 366,6 k € | -3.7% | 380,6 k € | -11.3% | 429,2 k € | -21.9% | 549,6 k € | -74.6% | 2,2 M € | -35.8% | 3,4 M € | -22.7% | 4,4 M € | +180.9% | 1,6 M € | +32.3% | 1,2 M € | +46.7% | 800,1 k € | -34.4% | 1,2 M € | |
| Cash | 248,8 k € | +50.6% | 165,2 k € | +46.5% | 112,8 k € | +21.5% | 92,9 k € | -52.0% | 193,3 k € | -77.4% | 855,8 k € | -7.5% | 925,5 k € | -61.6% | 2,4 M € | +66.8% | 1,4 M € | +35.5% | 1,1 M € | +45.2% | 735,9 k € | -35.7% | 1,1 M € | |
| Debts | 247,0 € | — | 4,4 k € | — | 57,3 k € | -97.6% | 2,4 M € | +78.0% | 1,4 M € | +1002.3% | 122,6 k € | -17.7% | 149,1 k € | -48.2% | 287,9 k € | +238.8% | 85,0 k € | +59.5% | 53,3 k € | |||||
| Staff | — | — | — | — | 5 | 10 | 11,6 | 8,6 | 6,7 | 4,3 | 3 | 2,7 | ||||||||||||
Public limited company loss-making in the latest fiscal year. Cash position rising (+50.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CoBioRes is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette